The content on this site is intended for healthcare professionals only
Dr Joaquin Mateo speaks to ecancer about his talk from the ESMO 2022 special session.
He discusses complex technologies for advanced diagnosis and precision medicine in oncology.
Dr Mateo initially explains the promise of precision medicine and how it can open avenues to improved cancer treatment. He then talks about the ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe.
Dr Mateo further discusses drug access, decision support tools, and ESMO recommendations on multigene NGS.
He concludes by talking about incorporating ESCAT and ESMO guidelines in the recommendations for biomarker testing and drug matching.
Burden and trends of breast cancer worldwide: Opportunities for prevention?
Key insights from lung cancer research at ASCO 2025
Advancements in paediatric Acute lymphoblastic leukemia management
Enhancing head and neck oncology: Key insights from the conference
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
Lung Cancer
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC
Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC
